Clinical Trial Update: NAC as a Potential Treatment for Methamphetamine Dependence [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating N-acetylcysteine as a potential treatment for methamphetamine use disorder has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Dependence
• Methamphetamine Use Disorder
• Substance Use Disorder

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Methamphetamine Abuse, Methamphetamine Dependence | Phase 1 | Status: COMPLETED